Ads
related to: keytruda- View Efficacy Data
Find Clinical Trial Results for
Treatment With KEYTRUDA.
- Prep and Admin Info
Learn About Preparation, Storage,
and Administration for KEYTRUDA.
- Professional Resources
Download HCP Resources, Including
Patient Monitoring Guides and More.
- MOA for KEYTRUDA
Find Professional Resources for
Mechanism of Action and More.
- KEY+YOU Information
Learn About KEY+YOU Patient Support
Program for Your Eligible Patients.
- Safety Information
View Selected Adverse Reaction
Information for KEYTRUDA.
- View Efficacy Data
Search results
Anti-Cancer Drug Pembrolizumab: Frequently Used Alone Or With Other Treatments
Forbes· 10 hours agoPembrolizumab, sold as Keytruda by Merck & Co., was one of the first inhibitors to hit the market. A...
ASCO24: An early look at cancer drug study results
BioPharma Dive via Yahoo Finance· 4 days agoClinical trial abstracts posted Thursday ahead of this year’s ASCO meeting give a peek at anticipated datasets from Immunocore, Merus, J&J and Merck &...
Iovance (IOVA) Up 5% on Updated Data From Melanoma Study
Zacks· 3 days agoFree Report) announced updated clinical results from a cohort of the phase II IOV-COM-202 study evaluating the combination of its recently approved cell therapy Amtagvi and Merck’s blockbuster ...
Why Merck (MRK) is a Top Momentum Stock for the Long-Term
Zacks via Yahoo Finance· 5 days agoMerck (MRK) Based in Kenilworth, NJ, Merck & Co. boasts more than six blockbuster products in its...
TME Pharma Announces Convocation of the 2024 Annual General Meeting of Shareholders
Morningstar· 9 hours agoTME Pharma N.V. (Euronext Growth Paris: ALTME) (Paris:ALTME),a biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumor microenvironment (TME ...
ASCO 2024: Merus touts positive Phase II data for head and neck cancer antibody
Pharmaceutical Technology via Yahoo Finance· 3 days agoThe Phase II study is evaluating petosemtamab in combination with Merck & Co’s PD-1 inhibitor ...
Cancer Biotech Stocks Are on the Move Ahead of a Big Event. What to Know.
Barrons.com· 3 days agoThe American Society of Clinical Oncology is set to gather on May 31 in Chicago for its annual...
Why Is Cancer-Focused Merus Stock Trading Over 30% On Friday?
Benzinga via Yahoo Finance· 3 days agoKeytruda (pembrolizumab) is Merck & Co Inc’s (NYSE:MRK) top selling cancer drug. The abstract...
Immunotherapy for stomach cancer: Types and effectiveness
Medical News Today· 5 days agoImmunotherapy may help shrink a tumor or slow the growth of cancer cells. People may have it in...
Is Merck & Co., Inc. (NYSE:MRK) the Best Dow Stock To Buy According to Hedge Funds?
Insider Monkey via Yahoo Finance· 2 days agoWe recently identified the best dow stocks according to hedge funds. Even though Merck & Co., Inc....